|
Real-time Estimate
Cboe BZX
23:11:59 20/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 302.86 USD | +1.65% |
|
+7.28% | -13.76% |
| 10-14 | Stryker Launches Sonopet 3, Delivering Greater Power And Precision In Ultrasonic Tissue Removal | CI |
| 10-14 | Stryker Receives FDA Clearance for Ultrasonic Tissue Removal Platform | MT |
| Market Cap | 114B 102B 94.28B 85.43B 161B 10,826B 163B 1,131B 444B 5,666B 429B 420B 18,074B | P/E 2026 * |
23.2x | P/E 2027 * | 20.3x |
|---|---|---|---|---|---|
| Enterprise Value | 124B 110B 102B 92.34B 174B 11,703B 176B 1,223B 480B 6,124B 463B 454B 19,537B | EV / Sales 2026 * |
4.55x | EV / Sales 2027 * | 4.07x |
| Free-Float |
94.9% | Yield 2026 * |
1.21% | Yield 2027 * | 1.28% |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| SYK | Delayed | |
CBOE
| SYK | Real-time | |
|
Mexican S.E.
| SYK * | End-of-day quote | |
|
Tradegate
| SYK | Real-time | |
|
Boerse Muenchen
| SYK | Real-time | |
|
Xetra
| SYK | Delayed | |
|
Börse Stuttgart
| SYK | Delayed | |
|
Wiener Boerse
| SYK | End-of-day quote | |
|
Deutsche Boerse AG
| SYK | Delayed | |
|
London S.E.
| 0R2S | Delayed | |
|
Borsa Italiana
| 1SYK | End-of-day quote | |
|
CBOE
| 0R2S | Real-time | |
|
CBOE
| Real-time |
Last Transcript: Stryker Corporation
| 1 day | +1.58% | ||
| 1 week | +7.28% | ||
| Current month | +10.07% | ||
| 1 month | +10.55% | ||
| 3 months | -5.02% | ||
| 6 months | -10.41% | ||
| Current year | -13.76% |
| 1 week | 278.58 |  | 304.98 |
| 1 month | 268.69 | | 304.98 |
| Current year | 267 | | 389.33 |
| 1 year | 267 | | 392.55 |
| 3 years | 255.22 | | 406.19 |
| 5 years | 188.84 | | 406.19 |
| 10 years | 106.48 | | 406.19 |
| Manager | Title | Age | Since |
|---|---|---|---|
Kevin Lobo
CEO | Chief Executive Officer | 60 | 01/10/2012 |
Spencer Stiles
PSD | President | 49 | 01/01/2026 |
Preston Wells
DFI | Director of Finance/CFO | 50 | 01/04/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Howard Cox
BRD | Director/Board Member | 82 | 01/01/1974 |
Ronda Stryker
BRD | Director/Board Member | 71 | 01/01/1984 |
Kevin Lobo
CHM | Chairman | 60 | 22/07/2014 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 24/09/26 | Others | Chief Financial Officer | -109 | 0.0000% | ||
| 22/09/26 | Others | Chief Financial Officer | -962 | 0.0003% | ||
| 01/09/26 | Other | Controller/Auditor | 7,092 | 0.0018% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.65% | +7.28% | -20.49% | +14.09% | 114B | |
| -2.12% | -1.24% | -21.75% | +4.71% | 180B | |
| +1.57% | +1.39% | -1.69% | +29.71% | 114B | |
| -1.02% | +2.87% | -52.05% | -7.70% | 78.39B | |
| +0.75% | +3.70% | +4.56% | +81.36% | 64.88B | |
| +1.60% | +3.73% | +17.39% | +76.86% | 54.02B | |
| +1.22% | +3.07% | +1.11% | -25.33% | 51.96B | |
| -0.19% | +6.72% | -13.70% | +30.04% | 43.79B | |
| -0.71% | +0.46% | +24.88% | -0.60% | 32.45B | |
| +2.20% | +6.37% | -6.94% | -13.84% | 31.94B | |
| Average | +0.45% | +2.88% | -6.87% | +18.93% | 76.53B | |
| Weighted average by Cap. | +0.12% | +2.93% | -12.09% | +18.55% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 27.17B 24.18B 22.41B 20.31B 38.17B 2,574B 38.81B 269B 106B 1,347B 102B 99.8B 4,297B | 29.49B 26.25B 24.33B 22.04B 41.43B 2,794B 42.12B 292B 115B 1,462B 111B 108B 4,664B |
| Net income | 4.93B 4.39B 4.07B 3.68B 6.92B 467B 7.04B 48.78B 19.16B 244B 18.48B 18.1B 779B | 5.72B 5.09B 4.72B 4.28B 8.04B 542B 8.17B 56.63B 22.25B 284B 21.46B 21.01B 905B |
| Net Debt | 9.25B 8.23B 7.63B 6.91B 13B 876B 13.21B 91.57B 35.97B 459B 34.7B 33.98B 1,463B | 5.83B 5.19B 4.81B 4.36B 8.19B 552B 8.32B 57.67B 22.66B 289B 21.86B 21.4B 921B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 20/10/26 | $302.87 | +1.65% | 1,630,785 |
| 19/10/26 | $297.94 | +1.11% | 3,064,552 |
| 16/10/26 | $294.66 | +0.49% | 3,377,422 |
| 15/10/26 | $293.23 | +4.12% | 3,121,141 |
| 14/10/26 | $281.62 | -0.33% | 2,228,464 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SYK Stock
Select your edition
All financial news and data tailored to specific country editions
